Research in mice describes a molecular mechanism in fatty tissue that predisposes people to regain weight. This finding could help explain the ‘yo-yo effect’ ...
The holidays usually mean indulging in your favorite treats — but Thanksgiving may look very different if you’re on an injectable GLP-1 weight-loss medication such as ... Castro-Tié says patients are ...
Recently, an anonymous female celebrity spoke about why she turned to Ozempic. This inspired another public figure - this ...
State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...
Novo Nordisk said Monday it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market where it estimates more than 180 million people live with obesity.
State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...
Tirzepatide by Eli Lilly reduces heart failure risk in adults with HFpEF and obesity, showing promising results for both ...
Recent research in the US has found that those who stop using semaglutide (sold under brand names like Ozempic and WeGovy), ...
The study concluded that patients needed to continue taking the drug ... they have in any other physical or consultation in the past." Photo: Health Utah A specialized health and weight loss program ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback